novo nordisk mash - Search News

Order byBest matchMost fresh

News

Novo Nordisk shares pop

· 3d · on MSN

Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH

Novo Nordisk said on Friday the U.S. Food and Drug Administration has granted accelerated approval for its weight-loss drug Wegovy to treat a serious liver condition called metabolic dysfunction-associated steatohepatitis,

Continue reading

· 1d · on MSN

Novo Nordisk shares pop after Wegovy receives U.S. approval for liver disease

Fierce Pharma · 1d

Novo's Wegovy picks up 3rd indication with key FDA approval in the liver disease MASH

1don MSN

Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers

Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...

1d

Novo Nordisk's Loss Is Eli Lilly's Gain, And Vice Versa

Novo Nordisk A/S gains momentum with FDA approval for Wegovy and strategic pricing. Click for why Novo outshines Eli Lilly ...

5don MSN

Is Novo Nordisk facing its “Nokia moment”? Stock tumbles to $50 from a year-high of $139 amid disruptive rivals and shifting market forces

Novo Nordisks stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, ...

5d

The Zacks Analyst Blog Highlights Broadcom, Philip Morris International and Novo Nordisk

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results